loadpatents
Patent applications and USPTO patent grants for Skokos; Dimitris.The latest application filed is for "anti-gitr antibodies and uses thereof".
Patent | Date |
---|---|
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof Grant 11,453,721 - Murphy , et al. September 27, 2 | 2022-09-27 |
Anti-GITR antibodies and uses thereof Grant 11,414,494 - Delfino , et al. August 16, 2 | 2022-08-16 |
Bispecific anti-CD28 .times. anti-CD22 antibodies and uses thereof Grant 11,396,544 - Murphy , et al. July 26, 2 | 2022-07-26 |
Anti-gitr Antibodies And Uses Thereof App 20210340267 - Babb; Robert ;   et al. | 2021-11-04 |
Anti-gitr Antibodies And Uses Thereof App 20210147565 - Delfino; Frank ;   et al. | 2021-05-20 |
EGFR x CD28 MULTISPECIFIC ANTIBODIES App 20200299388 - Skokos; Dimitris ;   et al. | 2020-09-24 |
Anti-GITR antibodies and uses thereof Grant 10,738,126 - Delfino , et al. A | 2020-08-11 |
Bispecific Anti-cd28 X Anti-cd22 Antibodies And Uses Thereof App 20200239576 - Murphy; Andrew J. ;   et al. | 2020-07-30 |
Bispecific Anti-muc16 X Anti-cd28 Antibodies And Uses Thereof App 20200199233 - Murphy; Andrew J. ;   et al. | 2020-06-25 |
Bispecific Anti-psma X Anti-cd28 Antibodies And Uses Thereof App 20190389951 - Murphy; Andrew J. ;   et al. | 2019-12-26 |
Anti-gitr Antibodies And Uses Thereof App 20170355774 - Delfino; Frank ;   et al. | 2017-12-14 |
Combination Of Anti-pd-1 Antibodies And Radiation To Treat Cancer App 20170327567 - SKOKOS; Dimitris ;   et al. | 2017-11-16 |
Human Antibodies To Human Tnf-like Ligand 1a (tl1a) App 20170096491 - Classon; Brendan J. ;   et al. | 2017-04-06 |
Method of treating a TL1A-associated disease or disorder with human antibodies to TL1A Grant 9,556,277 - Classon , et al. January 31, 2 | 2017-01-31 |
Methods of treating diabetes with Dll4 antagonists Grant 8,889,133 - Skokos November 18, 2 | 2014-11-18 |
Methods of Treating Autoimmune Diseases with DLL4 Antagonists App 20140255429 - Skokos; Dimitris | 2014-09-11 |
Methods of treating autoimmune diseases with Dll4 antagonists Grant 8,765,125 - Skokos July 1, 2 | 2014-07-01 |
Human Antibodies to Human TNF-Like Ligand 1A (TL1A) App 20140120109 - Classon; Brendan J. ;   et al. | 2014-05-01 |
Human antibodies to human TNF-like ligand 1A (TL1A) Grant 8,642,741 - Classon , et al. February 4, 2 | 2014-02-04 |
Human Antibodies To Human Tnf-like Ligand 1a (tl1a) App 20120114654 - Classon; Brendan J. ;   et al. | 2012-05-10 |
Methods Of Treating Diseases With Dll4 Antagonists App 20110189176 - SKOKOS; Dimitris | 2011-08-04 |
Methods Of Treating Autoimmune Diseases With Dll4 Antagonists App 20110189200 - SKOKOS; Dimitris | 2011-08-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.